Novo Nordisk A/S (NOVO-B.CO)

DKK 771.6

(0.22%)

Gross Profit Summary of Novo Nordisk A/S

  • Novo Nordisk A/S's latest annual gross profit in 2023 was 196.49 Billion DKK , up 32.32% from previous year.
  • Novo Nordisk A/S's latest quarterly gross profit in 2024 Q2 was 57.78 Billion DKK , up 4.24% from previous quarter.
  • Novo Nordisk A/S reported a annual gross profit of 148.5 Billion DKK in annual gross profit 2022, up 26.77% from previous year.
  • Novo Nordisk A/S reported a annual gross profit of 117.14 Billion DKK in annual gross profit 2021, up 10.5% from previous year.
  • Novo Nordisk A/S reported a quarterly gross profit of 55.43 Billion DKK for 2024 Q1, down -0.74% from previous quarter.
  • Novo Nordisk A/S reported a quarterly gross profit of 46.44 Billion DKK for 2023 Q2, up 2.79% from previous quarter.

Annual Gross Profit Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Gross Profit of Novo Nordisk A/S (2023 - 1989)

Year Gross Profit Gross Profit Growth
2023 196.49 Billion DKK 32.32%
2022 148.5 Billion DKK 26.77%
2021 117.14 Billion DKK 10.5%
2020 106.01 Billion DKK 4.0%
2019 101.93 Billion DKK 8.19%
2018 94.21 Billion DKK 0.16%
2017 94.06 Billion DKK -0.56%
2016 94.59 Billion DKK 3.12%
2015 91.73 Billion DKK 23.56%
2014 74.24 Billion DKK 6.93%
2013 69.43 Billion DKK 7.54%
2012 64.56 Billion DKK 20.1%
2011 53.75 Billion DKK 9.49%
2010 49.09 Billion DKK 20.81%
2009 40.64 Billion DKK 14.37%
2008 35.53 Billion DKK 10.75%
2007 32.08 Billion DKK 10.02%
2006 29.16 Billion DKK 18.8%
2005 24.54 Billion DKK 16.19%
2004 21.12 Billion DKK 10.32%
2003 19.15 Billion DKK 3.36%
2002 18.52 Billion DKK 4.38%
2001 17.75 Billion DKK 8.01%
2000 16.43 Billion DKK 3.4%
1999 15.89 Billion DKK 17.54%
1998 13.52 Billion DKK 10.28%
1997 12.26 Billion DKK 14.21%
1996 10.73 Billion DKK 8.63%
1995 9.88 Billion DKK 2.06%
1994 9.68 Billion DKK 43.73%
1993 6.73 Billion DKK -17.27%
1992 8.14 Billion DKK 61.78%
1991 5.03 Billion DKK 19.67%
1990 4.2 Billion DKK 9.15%
1989 3.85 Billion DKK 32.3%

Peer Gross Profit Comparison of Novo Nordisk A/S

Name Gross Profit Gross Profit Difference
ALK-Abelló A/S 3.03 Billion DKK -6374.333%
Bavarian Nordic A/S 4.52 Billion DKK -4245.571%
Genmab A/S 16.24 Billion DKK -1109.355%
Gubra A/S 114.93 Million DKK -170861.231%
Orphazyme A/S - DKK -Infinity%
Pharma Equity Group A/S -480 Thousand DKK 40936766.667%
Zealand Pharma A/S 323.61 Million DKK -60619.252%